Market capitalization | $1.49b |
Enterprise Value | $3.66b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 22.01 |
EV/Sales (TTM) EV/Sales | 1.12 |
P/S ratio (TTM) P/S ratio | 0.46 |
P/B ratio (TTM) P/B ratio | 0.97 |
Revenue growth (TTM) Revenue growth | 6.05% |
Revenue (TTM) Revenue | $3.26b |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
9 Analysts have issued a AdaptHealth Corp - Ordinary Shares - Class A forecast:
9 Analysts have issued a AdaptHealth Corp - Ordinary Shares - Class A forecast:
Jun '24 |
+/-
%
|
||
Revenue | 3,261 3,261 |
6%
6%
|
|
Gross Profit | 465 465 |
39%
39%
|
|
EBITDA | 690 690 |
8%
8%
|
EBIT (Operating Income) EBIT | 276 276 |
64%
64%
|
Net Profit | -693 -693 |
1,861%
1,861%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses providing sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.
Head office | United States |
CEO | Suzanne Foster |
Employees | 10,700 |
Founded | 2012 |
Website | www.adapthealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.